Cannabisnewsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) …

(MENAFN– Investor Brand Network) , a global innovator in drug delivery platforms, has announced that study program DIAB-A22-1 is expected to begin on schedule today. According to the announcement, this is Lexaria’s first-ever study to investigate whether its patented DehydraTECH-processed cannabidiol (“CBD”) may potentially have therapeutic utility against diabetes. The ... Read More

CBDCapitalGroup Welcomes Cannabis Industry Leader and Innovator Kimberly Kovacs to Company’s Advisory Council

/EIN News/ — SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — CBDCapitalGroup (“CCG” or the “Company”), a CBD nutraceuticals investment and scaling company, today announced that respected cannabis industry leader and innovator Kimberly Kovacs has joined the Company’s Advisory Council. Through her current and previous roles, Kovacs has ... Read More